Overseas Chinese Equities, Aequitas Research

Ming Lu

A veteran with 19-year experience in equity research.

Geographical coverage:
* Companies operating in China, but listed in Hong Kong and the U.S.
* Previously China A-share (listed in mainland China).

Equity sector coverage:
* Chinese App / Internet-based consumption in China, e.g., Alibaba, Tencent, etc.
* Previously covered education, transportation, telecom, power, bank, advertisement, hotel, etc.

Research methods:
* Generally bottom-up.
* Talk to related people on the ground.  Talk to readers and independent writers for analyzing a news portal.  Talk to parents and teachers for analyzing a tutoring school. 
* Visit stores and show photos as evidence in notes.
* Do technical analysis when finding a short-seller attacking an equity.

Languages:
* English
* Mandarin Chinese (Official language of China)
* Shanghainese (Language of Shanghai, the most developed city in China)
* Cantonese (Language of Hong Kong and Canton Province, one of the most developed provinces in China)

Overseas Chinese Equities

JD.com (9618 HK): 3Q22, Growth Recovered, Margin Reached Historical High

China Internet Weekly (5Dec2022): JD.com, Baidu, IQiyi, Alibaba Health, ZTO, Pinduoduo, KE

JD.com (9618 HK) Earnings Preview: Weak Q4, But Strong 2023

JD.com (9618) Support Break to Reach Our Buy Zone

China Internet Weekly (11Jul2022): JD.com, Alibaba, Suning.com, GoGoX

JD.com (9618 HK): Pre-2Q22 Earnings, Will Slow Down and Then Recover from Lockdown

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<ul>
<li>The revenue growth rate fell to 5% in 2Q22 due to the lockdown in Shanghai and Yangtze delta.</li>
<li>However, freezers became popular in June and July because of the experience during the lockdown.</li>
<li>We believe the stock has an upside of 21% based on EBITDA, but the upside can be significant if based on sales-related ratios.</li>
</ul>


The revenue growth rate fell to 5% in 2Q22 due to the lockdown in Shanghai and Yangtze delta.
However, freezers became popular in June and July because of the experience during the lockdown.
We believe the stock has an upside of 21% based on EBITDA, but the upside can be significant if based on sales-related ratios.


JD.com (9618 HK): 2Q22, Growth Tumbled, But Lockdown Eased, 20% Upside or More